A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

NCT04530110 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

506

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Fremanezumab

Sponsor

Teva Branded Pharmaceutical Products R&D LLC